The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biodyn Share News (OBD)

Share Price Information for Oxford Biodyn (OBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.90
Bid: 7.60
Ask: 7.94
Change: 0.12 (1.54%)
Spread: 0.34 (4.474%)
Open: 7.90
High: 7.90
Low: 7.90
Prev. Close: 7.78
OBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle

Wed, 30th Dec 2020 19:10

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Wednesday and not separately reported by Alliance News:

----------

Tate & Lyle PLC - London-headquartered food and beverage ingredients firm - Hires John Cheung, currently an executive director at nutrition group China Feihe Ltd, as a non-executive director effective Friday. Cheung's experience includes being president for Wyeth Nutrition Global, Nestle SA's leader in China, and senior roles with both Coca-Cola Co and Procter & Gamble Co. Tate & Lyle further announces the upcoming departure of Non-Executive Director Ajai Puri, who will retire March 31 after close to nine years on the board.

----------

Flutter Entertainment PLC - Dublin, Ireland-based bookmaker - Non-Executive Director Ian Dyson steps down effective Thursday. Chair Gary McGann thanks the outgoing director "for his outstanding contribution to the board over the past 10 years."

----------

Robert Walters PLC - London-based recruitment firm - Ron Mobed, who joined the company board as chair designate on December, is to formally succeed Carol Hui as non-executive chair on Friday this week. Hui will depart the board after a nine-year tenure effective Thursday.

----------

Vectura Group PLC - Chippenham, Wiltshire-based inhaled drug delivery solutions firm - Appoints Jeanne Hecht, most recently chief executive of pre-clinical and clinical ophthalmic drug and device development firm Ora Inc, and Jeanne Thoma as independent non-executive directors effective Thursday. Thoma was most recently CEO & president of SPI Pharma, a specialist formulation and ingredient services business.

----------

Samuel Heath & Sons PLC - shower and bathroom accessory manufacturer - Managing Director David Pick retires effective Thursday, as announced February 2020. He is succeeded by Martyn Whieldon, currently deputy managing director at Samuel Heath & Sons.

----------

Oxford BioDynamics PLC - biotechnology firm focused on discovery and development of epigenetic biomarkers - Christian Millar, an executive director, is to retire from the board on Thursday. Millar, formerly chief executive of Oxford BioDynamics before bringing in Jon Burrows as successor earlier in 2020, co-founded the company in 2008 alongside Alexandre Akoulitchev and Aroul Ramadass.

----------

AIQ Ltd - focused on acquiring and developing e-commerce sector businesses - Hires Li Chun Chung as an executive director with immediate effect. The new director "has over 20 years' experience in assisting companies with their strategic growth." Additionally, AIQ Non-Executive Director Soon Beng Gee and Executive Director Lee Chong Liang resign with immediate effect.

----------

Borders & Southern Petroleum PLC - London-based independent oil & gas exploration company with assets offshore the Falkland Islands - Effective Friday, Non-executive Director Nigel Hurst-Brown retires from the board. At the same time, Borders & Southern hires William Hodson as non-executive director. Hodson has "a long standing background in corporate finance and capital markets, with significant experience in the resource sector." Also appoints Auctus Advisors LLP and Strand Hanson Ltd to act as joint brokers.

----------

DWF Group PLC - Manchester-based law firm - Independent Non-Executive Director Vinodka Murria resigns with immediate effect in order to "pursue new business opportunities in the technology arena" and also steps down as a member of the firm's audit, risk, remuneration and nomination committees. The search for her successor has begun.

----------

By Anna Farley; annafarley@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
31 May 2019 13:01

Long-Serving Oxford Biodynamics Non-Executive Kibble Stands Down

LONDON (Alliance News) - Biotechnology firm Oxford Biodynamics PLC said Friday Non-Executive Director Alison Kibble has stepped down from the firm after 11 years on the board.Kibble - first

Read more
28 May 2019 11:50

Oxford BioDynamics Half Year Loss Widens On Increased Costs

LONDON (Alliance News) - Oxford BioDynamics PLC on Tuesday said its loss widened in the first half of its financial year due to higher staff and administrative costs.Shares in Oxford were a

Read more
21 May 2019 16:05

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 22 May Marks & Spencer GroupFull Year ResultsRoyal MailFull Year Year Year

Read more
3 May 2019 14:19

Oxford BioDynamics Chosen To Join ALS Biomarker Study

LONDON (Alliance News) - Oxford Biodynamics PLC said on Friday it has joined the REFINE-ALS study, designed to identify specific biomarkers in people with amyotrophic lateral sclerosis.The

Read more
23 Apr 2019 10:33

Three AIM firms celebrate Queen's Award for Enterprise wins

(Sharecast News) - Three firms trading on London's AIM market were celebrating wins in the Queen's Award for Enterprise on Tuesday, with Inspiration Healthcare, Ergomed and Oxford BioDynamics all picking up the accolades.

Read more
5 Apr 2019 11:25

Oxford BioDynamics Appoints Non-Executive Director As Interim Chair

LONDON (Alliance News) - Oxford BioDynamics PLC said on Friday it has promoted Non-Executive Director Steven Wiggle as interim chair with immediate effect.Wiggle will be replacing David who

Read more
2 Apr 2019 12:08

Oxford BioDynamics Launches US Business With New Commerical Head

LONDON (Alliance News) - Biotechnology firm Oxford BioDynamics PLC said Tuesday it has established a US subsidiary and appointed a commercial head for the country.In line with its strategy

Read more
19 Mar 2019 11:54

Oxford BioDynamics EpiSwitch Test Included In Cancer Screening Study

LONDON (Alliance News) - Oxford BioDynamics PLC on Tuesday said it has signed an agreement for its EpiSwitch test to be used by Imperial College London in a prostate cancer screening College is to

Read more
19 Mar 2019 11:43

Oxford BioDynamics biomarker to be used in prostate cancer test trial

(Sharecast News) - Oxford BioDynamics announced on Tuesday that it has signed an agreement with Imperial College London, to utilise its latest 'EpiSwitch' biomarker signature for the blood-based diagnosis of prostate cancer in the 'PROSTAGRAM' trial.

Read more
15 Feb 2019 14:55

DIRECTOR DEALINGS: Oxford BioDynamics Non-Exec's Associate Buys Shares

LONDON (Alliance News) - Oxford BioDynamics PLC on Friday said that the Vulpie Life Sciences Fund, controlled by Non-Executive Director Steven Diggle, purchased nearly GBP37,000 in stock over two

Read more
11 Jan 2019 10:21

Oxford Biodynamics Chair And Long-Serving Non-Exec To Stand Down

LONDON (Alliance News) - Biotechnology company Oxford Biodynamics PLC said Friday Chair David Williams and Non-Executive Director Alison Kibble will stand down later in 2019.Williams - 2016

Read more
11 Dec 2018 11:47

Oxford BioDynamics Annual Loss Narrows On Lower Costs

LONDON (Alliance News) - Oxford BioDynamics PLC on Tuesday reported a sharply narrowed annual loss due to absence of initial public offering related costs.For the year ended September 30, a

Read more
29 Aug 2018 17:03

GL Healthcare Holds 5% Oxford Biodynamics Stake After Deal (ALLISS)

LONDON (Alliance News) - Oxford Biodynamics PLC said Wednesday that GL Healthcare Investment LP holds a 5.1% stake in the biotechnology company after a transaction on Tuesday.GL holding the

Read more
22 Aug 2018 10:26

Chinese Investor Chooses Oxford BioDynamics As First European Partner (ALLISS)

LONDON (Alliance News) - Oxford BioDynamics PLC on Wednesday said a Chinese investment management firm has invested GBP9.8 million in the company.GL Capital Group, which focuses on firms, a

Read more
22 Aug 2018 08:39

Oxford BioDynamics sets sights on China following GL investment

(Sharecast News) - AIM-listed biotechnology company Oxford BioDynamics has launched a strategic partnership with GL Capital, a Chinese healthcare-focused investment group.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.